COVID-19 Update

COVID-19 has imposed an unsettling situation upon our community and our business, but at Cleveland Diabetes Care and our affiliates, KRS Global Biotechnology and Complete Pharmacy Medical Solutions, we are committed to fighting back the best way we know how. By providing better medicine for better lives we will continue operations that include creation and distribution of life saving medications and testing kits to all reaches of our great nation.

Press Releases

16

June
2020
PRESS
RELEASE

KRS Global Biotechnology Acquired By Cleveland Diabetes Care

World-Renowned Dr. Charles Richardson to lead the company’s expansion BOCA RATON, Fla., June 16, 2020 /PRNewswire/ — KRS Global Biotechnology, Inc., a market-leading registered and inspected 503B Human Outsourcing Facility, is under new ownership and management as of Q1 2020.  Cleveland Diabetes Care, Inc. (CDC), a clinical-stage biopharmaceutical, gene therapy, and medical devices technologies company based in Boca Raton, Florida, acquired […]

27

October
2016
PRESS
RELEASE

KRS Global Biotechnology Named Finalist for the Manufacturers Association of Florida Manufacturer of the Year

KRS is once again honored to be nominated as the Manufacturer of the Year but the Manufacturers Association of Florida.  Thank you to the judges but also to each and every employee who has made all of this possible.  #krsbio for-immediate-release  

11

May
2016
PRESS
RELEASE

KRS L-Asparaginase Used In Study

Use of compounded L-asparaginase became routine in veterinary oncology when manufacturing of Elspar® was discontinued in 2012. The objective of this study was to evaluate the safety of compounded L-asparaginase (CLASP, KRS Global Biotechnology, Boca Raton, FL, USA) in comparison with Elspar® (Lundbeck LLC, Deerfield, IL, USA).

  1. 1
  2. 2
  3. 3
  4. 4